APO RESEARCH · REPORT
Cetirizine Hydrochloride
Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria. It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.
Product & engineering
Understand the product.
Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria. It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.
Selected research
Industry Research
Cetirizine Hydrochloride Industry Research Report 2026
Market perspective
Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria. It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.
The major players in the industry are J & J, UCB Pharma, GSK, etc. The proportion of revenue in 2019 is 29.00%, 25.87%, 11.39%. North America has the highest market share by region, accounting for more than 33.8 percent of revenue.
Report Scope
Read the full market overview
This report quantifies the global Cetirizine Hydrochloride market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cetirizine Hydrochloride Market by Company
J & J
UCB Pharma
GSK
Teva
HUAPONT Pharm
Sun Pharma
Hunan Jiudian Pharm
Lunan Pharma
Mylan
Apotex
Jubilant Life Sciences
HAILISHENG
Cetirizine Hydrochloride Segment by Type
Tablet
Capsule
Solution
Cetirizine Hydrochloride Segment by Application
Hospital
Drug Store
Others
Cetirizine Hydrochloride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cetirizine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cetirizine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cetirizine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cetirizine Hydrochloride manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cetirizine Hydrochloride by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cetirizine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
- Solution
Applications
- Hospital
- Drug Store
- Others
Companies covered
- J & J
- UCB Pharma
- GSK
- Teva
- HUAPONT Pharm
- Sun Pharma
- Hunan Jiudian Pharm
- Lunan Pharma
- Mylan
- Apotex
- Jubilant Life Sciences
- HAILISHENG
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cetirizine Hydrochloride Market Size (2021-2032)
- 2.2.2 Global Cetirizine Hydrochloride Sales (2021-2032)
- 2.2.3 Global Cetirizine Hydrochloride Market Average Price (2021-2032)
- 2.3 Cetirizine Hydrochloride by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Capsule
- 2.3.4 Solution
- 2.4 Cetirizine Hydrochloride by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Drug Store
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cetirizine Hydrochloride Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cetirizine Hydrochloride Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Cetirizine Hydrochloride Revenue of Manufacturers (2021-2026)
- 3.4 Global Cetirizine Hydrochloride Average Price by Manufacturers (2021-2026)
- 3.5 Global Cetirizine Hydrochloride Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cetirizine Hydrochloride, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cetirizine Hydrochloride, Product Type & Application
- 3.8 Global Manufacturers of Cetirizine Hydrochloride, Established Date
- 3.9 Global Cetirizine Hydrochloride Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 J & J
- 4.1.1 J & J Company Information
- 4.1.2 J & J Business Overview
- 4.1.3 J & J Cetirizine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 J & J Cetirizine Hydrochloride Product Portfolio
- 4.1.5 J & J Recent Developments
- 4.2 UCB Pharma
- 4.2.1 UCB Pharma Company Information
- 4.2.2 UCB Pharma Business Overview
- 4.2.3 UCB Pharma Cetirizine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 UCB Pharma Cetirizine Hydrochloride Product Portfolio
- 4.2.5 UCB Pharma Recent Developments
- 4.3 GSK
- 4.3.1 GSK Company Information
- 4.3.2 GSK Business Overview
- 4.3.3 GSK Cetirizine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GSK Cetirizine Hydrochloride Product Portfolio
- 4.3.5 GSK Recent Developments
- 4.4 Teva
- 4.4.1 Teva Company Information
- 4.4.2 Teva Business Overview
- 4.4.3 Teva Cetirizine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teva Cetirizine Hydrochloride Product Portfolio
- 4.4.5 Teva Recent Developments
- 4.5 HUAPONT Pharm
- 4.5.1 HUAPONT Pharm Company Information
- 4.5.2 HUAPONT Pharm Business Overview
- 4.5.3 HUAPONT Pharm Cetirizine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 HUAPONT Pharm Cetirizine Hydrochloride Product Portfolio
- 4.5.5 HUAPONT Pharm Recent Developments
- 4.6 Sun Pharma
- 4.6.1 Sun Pharma Company Information
- 4.6.2 Sun Pharma Business Overview
- 4.6.3 Sun Pharma Cetirizine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sun Pharma Cetirizine Hydrochloride Product Portfolio
- 4.6.5 Sun Pharma Recent Developments
- 4.7 Hunan Jiudian Pharm
- 4.7.1 Hunan Jiudian Pharm Company Information
- 4.7.2 Hunan Jiudian Pharm Business Overview
- 4.7.3 Hunan Jiudian Pharm Cetirizine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hunan Jiudian Pharm Cetirizine Hydrochloride Product Portfolio
- 4.7.5 Hunan Jiudian Pharm Recent Developments
- 4.8 Lunan Pharma
- 4.8.1 Lunan Pharma Company Information
- 4.8.2 Lunan Pharma Business Overview
- 4.8.3 Lunan Pharma Cetirizine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lunan Pharma Cetirizine Hydrochloride Product Portfolio
- 4.8.5 Lunan Pharma Recent Developments
- 4.9 Mylan
- 4.9.1 Mylan Company Information
- 4.9.2 Mylan Business Overview
- 4.9.3 Mylan Cetirizine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Mylan Cetirizine Hydrochloride Product Portfolio
- 4.9.5 Mylan Recent Developments
- 4.10 Apotex
- 4.10.1 Apotex Company Information
- 4.10.2 Apotex Business Overview
- 4.10.3 Apotex Cetirizine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Apotex Cetirizine Hydrochloride Product Portfolio
- 4.10.5 Apotex Recent Developments
- 4.11 Jubilant Life Sciences
- 4.11.1 Jubilant Life Sciences Company Information
- 4.11.2 Jubilant Life Sciences Business Overview
- 4.11.3 Jubilant Life Sciences Cetirizine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Jubilant Life Sciences Cetirizine Hydrochloride Product Portfolio
- 4.11.5 Jubilant Life Sciences Recent Developments
- 4.12 HAILISHENG
- 4.12.1 HAILISHENG Company Information
- 4.12.2 HAILISHENG Business Overview
- 4.12.3 HAILISHENG Cetirizine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 HAILISHENG Cetirizine Hydrochloride Product Portfolio
- 4.12.5 HAILISHENG Recent Developments
5 Global Cetirizine Hydrochloride Market Scenario by Region
- 5.1 Global Cetirizine Hydrochloride Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cetirizine Hydrochloride Sales by Region: 2021-2032
- 5.2.1 Global Cetirizine Hydrochloride Sales by Region: 2021-2026
- 5.2.2 Global Cetirizine Hydrochloride Sales by Region: 2027-2032
- 5.3 Global Cetirizine Hydrochloride Revenue by Region: 2021-2032
- 5.3.1 Global Cetirizine Hydrochloride Revenue by Region: 2021-2026
- 5.3.2 Global Cetirizine Hydrochloride Revenue by Region: 2027-2032
- 5.4 North America Cetirizine Hydrochloride Market Facts & Figures by Country
- 5.4.1 North America Cetirizine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cetirizine Hydrochloride Sales by Country (2021-2032)
- 5.4.3 North America Cetirizine Hydrochloride Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cetirizine Hydrochloride Market Facts & Figures by Country
- 5.5.1 Europe Cetirizine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cetirizine Hydrochloride Sales by Country (2021-2032)
- 5.5.3 Europe Cetirizine Hydrochloride Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cetirizine Hydrochloride Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cetirizine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cetirizine Hydrochloride Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cetirizine Hydrochloride Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cetirizine Hydrochloride Market Facts & Figures by Country
- 5.7.1 South America Cetirizine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cetirizine Hydrochloride Sales by Country (2021-2032)
- 5.7.3 South America Cetirizine Hydrochloride Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cetirizine Hydrochloride Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cetirizine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cetirizine Hydrochloride Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cetirizine Hydrochloride Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cetirizine Hydrochloride Sales by Type (2021-2032)
- 6.1.1 Global Cetirizine Hydrochloride Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Cetirizine Hydrochloride Sales Market Share by Type (2021-2032)
- 6.2 Global Cetirizine Hydrochloride Revenue by Type (2021-2032)
- 6.2.1 Global Cetirizine Hydrochloride Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cetirizine Hydrochloride Revenue Market Share by Type (2021-2032)
- 6.3 Global Cetirizine Hydrochloride Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cetirizine Hydrochloride Sales by Application (2021-2032)
- 7.1.1 Global Cetirizine Hydrochloride Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Cetirizine Hydrochloride Sales Market Share by Application (2021-2032)
- 7.2 Global Cetirizine Hydrochloride Revenue by Application (2021-2032)
- 7.2.1 Global Cetirizine Hydrochloride Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cetirizine Hydrochloride Revenue Market Share by Application (2021-2032)
- 7.3 Global Cetirizine Hydrochloride Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cetirizine Hydrochloride Value Chain Analysis
- 8.1.1 Cetirizine Hydrochloride Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cetirizine Hydrochloride Production Mode & Process
- 8.2 Cetirizine Hydrochloride Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cetirizine Hydrochloride Distributors
- 8.2.3 Cetirizine Hydrochloride Customers
9 Global Cetirizine Hydrochloride Analyzing Market Dynamics
- 9.1 Cetirizine Hydrochloride Industry Trends
- 9.2 Cetirizine Hydrochloride Industry Drivers
- 9.3 Cetirizine Hydrochloride Industry Opportunities and Challenges
- 9.4 Cetirizine Hydrochloride Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst